Screening of dementia genes by whole-exome sequencing in Spanish patients with early-onset dementia: likely pathogenic, uncertain significance and risk variants.
ATP-Binding Cassette Transporters
/ genetics
Alzheimer Disease
/ genetics
Female
Genetic Association Studies
/ methods
Genetic Variation
Humans
LDL-Receptor Related Proteins
/ genetics
Male
Membrane Glycoproteins
/ genetics
Membrane Transport Proteins
/ genetics
Middle Aged
Mutation
Presenilin-1
/ genetics
Receptors, Immunologic
/ genetics
Retrospective Studies
Risk
Risk Factors
Sequestosome-1 Protein
/ genetics
Spain
Valosin Containing Protein
/ genetics
Exome Sequencing
Alzheimer disease
Frontotemporal dementia
Mutation
Variant
Whole-exome sequencing
Journal
Neurobiology of aging
ISSN: 1558-1497
Titre abrégé: Neurobiol Aging
Pays: United States
ID NLM: 8100437
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
13
09
2019
revised:
09
01
2020
accepted:
12
02
2020
pubmed:
23
4
2020
medline:
16
1
2021
entrez:
23
4
2020
Statut:
ppublish
Résumé
Early-onset Alzheimer's disease (EOAD) and frontotemporal dementia (FTD) have a high proportion of genetically determined cases. Next-generation sequencing technologies have triggered the discovery of new mutations and genetic variants in dementia-causal genes. We performed whole-exome sequencing and selective analysis of known genes causative of EOAD and FTD in a well-characterized Spanish cohort of 103 patients (60 EOAD, 43 FTD) to find genetic variants associated to patients' phenotype. In EOAD patients, a new likely pathogenic variant in PSEN1 gene (p.G378R) was found. In FTD patients, 2 likely pathogenic variants were found, one in MAPT gene (p.P397S) and one in VCP gene (p.R159H). In our series, 2% of early-onset dementia without criteria for clinical genetic testing according to current guidelines presented a likely pathogenic mutation. We have also detected 13 additional variants of uncertain significance in causal genes, as well as rare variants in risk genes for dementia (ABCA7, SORL1, SQSTM1, and TREM2). Next-generation technologies in neurodegenerative diseases constitute a powerful tool that significantly contributes to patients' diagnosis.
Identifiants
pubmed: 32317127
pii: S0197-4580(20)30035-X
doi: 10.1016/j.neurobiolaging.2020.02.008
pii:
doi:
Substances chimiques
ABCA7 protein, human
0
ATP-Binding Cassette Transporters
0
LDL-Receptor Related Proteins
0
Membrane Glycoproteins
0
Membrane Transport Proteins
0
PSEN1 protein, human
0
Presenilin-1
0
Receptors, Immunologic
0
SORL1 protein, human
0
SQSTM1 protein, human
0
Sequestosome-1 Protein
0
TREM2 protein, human
0
VCP protein, human
EC 3.6.4.6
Valosin Containing Protein
EC 3.6.4.6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1-e9Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.